Inactive Instrument
RAMM Pharma Corp. Share Price OTC Markets
Stocks
RAMMF
CA75150G1046
Pharmaceuticals
OTC Markets Traded| Market Cap | 11.94L 9L 7L 7L 6L 8.1Cr 12.15L 81.33L 31.85L 4.04Cr 31.93L 31.22L 13Cr | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 5L 3L 3L 3L 2L 3.19Cr 5L 32.04L 12.55L 1.59Cr 12.58L 12.3L 5.25Cr | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -76.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 01/10/2019 |
José Roldan
DFI | Director of Finance/CFO | - | 09/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 01/10/2019 |
Daniel Augereau
BRD | Director/Board Member | 82 | 01/10/2019 |
Eric Klein
BRD | Director/Board Member | 66 | 01/10/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -76.29% | -92.33% | - | - | 9L | ||
| +0.47% | -7.38% | +47.02% | +151.53% | 1LCr | ||
| -0.71% | -5.20% | +47.84% | +49.59% | 61TCr | ||
| +0.14% | -6.44% | +24.88% | +66.70% | 43TCr | ||
| +0.96% | -2.17% | +41.14% | +35.79% | 35TCr | ||
| +0.31% | -4.08% | +32.25% | +40.43% | 29TCr | ||
| +1.56% | -9.61% | +5.03% | +7.20% | 24TCr | ||
| +2.03% | -8.05% | -1.47% | -41.90% | 21TCr | ||
| +1.01% | -2.42% | +27.04% | +57.67% | 20TCr | ||
| +0.10% | -2.32% | +14.58% | +66.76% | 16TCr | ||
| Average | -7.05% | -3.88% | +26.48% | +48.20% | 38.89TCr | |
| Weighted average by Cap. | +0.43% | -4.34% | +34.21% | +71.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 43.42L 30.91L 26.87L 25.08L 23.03L 29Cr 44.18L 2.96Cr 1.16Cr 15Cr 1.16Cr 1.14Cr 48Cr | 33.61L 23.93L 20.8L 19.41L 17.82L 23Cr 34.19L 2.29Cr 89.66L 11Cr 89.88L 87.88L 38Cr |
| Net income | -1.65Cr -1.17Cr -1.02Cr -95.33L -87.52L -111.99Cr -1.68Cr -11Cr -4.4Cr -56Cr -4.41Cr -4.32Cr -184.2Cr | -89.1L -63.44L -55.13L -51.47L -47.25L -60Cr -90.65L -6.07Cr -2.38Cr -30Cr -2.38Cr -2.33Cr -99Cr |
| Net Debt | -6L -4L -4L -4L -3L -4.25Cr -6L -42.62L -16.69L -2.12Cr -16.73L -16.36L -6.98Cr | -7L -5L -4L -4L -4L -4.91Cr -7L -49.28L -19.3L -2.45Cr -19.35L -18.92L -8.08Cr |
Employees
-
Sector
Pharmaceuticals
















